SIM0686
Phase 1Small molecule
Jiangsu Simcere Pharmaceutical Co., Ltd.SIM0686 is one of 4 small molecule programs targeting Locally Advanced/Metastatic Solid Tumors. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
9 competitors in Locally Advanced/metastatic Solid Tumors
#DrugCompanyPhaseTrials
1Abraxane
Bristol-Myers SquibbPhase 2
Cytoxan
BBaxter Healthcare Corporation
Phase 2
Anti-PD-1 Monoclonal Antibody
IiTeos Therapeutics
Phase 2
SIM0686
Jiangsu Simcere Pharmaceutical Co., Ltd.Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for SIM0686. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details